Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2024-01-16 2023-11-20
Drug Identification Number 02247735 02247735
Brand name FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
Common or Proper name Famotidine Injection Famotidine Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients FAMOTIDINE FAMOTIDINE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 x 2 mL vial / fiole 10 x 2 mL vial / fiole
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-12-11 2023-12-11
Actual start date 2023-12-05
Estimated end date 2024-01-26 2024-01-12
Actual end date 2024-01-15
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments